rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Natco Pharma

Rediff.com  »  News  »   Natco Pharma

  News for Natco Pharma

  • Business

Natco, Cipla up after SC dismisses Novartis plea

Shares in Natco Pharma and Cipla gain after the Supreme Court on Monday dismissed Swiss drugmaker Novartis AG's petition seeking patent for its cancer drug Glivec.In a landmark judgment that has......

Natco medicine gets 'Orphan Drug' status

Natco Pharma's anti-cancer drug, NRC-AN-019, has received 'Orphan Drug' designation from the US Food and Drug Administration (USFDA) for three indications - glioma (brain tumour), pancreatic cancer......

Natco challenges Gilead's patent on Tamiflu

Hyderabad-based Natco Pharma has challenged the patent for Tamiflu - a drug to treat bird flu - in the US.The company has sought the United States Food and Drug Administration (FDA)'s approval to......

Natco opposes Novartis patent claim

Natco Pharma has opposed an application made by Novartis India to the controller of patents, for grant of a patent for an anti-cancer drug 'Imatinib Mesylate'. The company has filed a pre-grant......

Anti-migraine drug, from Natco

Natco Pharma has announced the launch of a new generation anti-migraine drug under the brand name 'Ritza'.The total migraine market in India is substantial and growing at the rate of 25 per cent......

  People speak for natco pharma

  • QNA
Q. Now Natco Pharma @154.30 is correct rate to buy.
:  A. yes, can buy for short term. more

http://qna.rediff.com/questions-and-answers/now-natco-pharma-154.30-is-correct-rate-to-buy.//answers/17161026

  Web results for Natco Pharma
Stocks as on May 22, 2013

D ata for 800 companies from Bombay Stock Exchange. Values are: days closing price, previous closing price in brackets, 52-week low and high in... ...

http://www.deccanherald.com/content/334014/stocks-may-22-2013.html
Natco recalls breast cancer drug 'Albupax'

Drug firm Natco Pharma today said it has stopped the production and marketing of breast cancer drug 'Albupax', after tests showed that it might... ...

http://www.mydigitalfc.com/companies/natco-recalls-breast-cancer-drug-albupax-508
Dr Reddy's says have factored in the impact

Pharma major Dr Reddy's Laboratories Ltd said the new pricing policy might impact 3-4 per cent of its finished dosage sales in the domestic market.... ...

http://www.thehindubusinessline.com/companies/dr-reddys-says-have-factored-in-the-impact/article4724629.ece
Stocks as on May 16, 2013.

Data for 800 companies from Bombay Stock Exchange. Values are: days closing price, previous closing price in brackets, 52-week low and high in... ...

http://www.deccanherald.com/content/332811/stocks-may-16-2013.html
Incentivising Innovation without compromising affordable healthcare

The recent judgement of the Supreme Court of India in the case of Novartis AG v Union of India[1] has highlighted the protective provisions of... ...

http://www.barandbench.com/content/indian-patents-act-incentivising-innovation-without-compromising-affordable-healthcare

Related Tags


  1. india
  2. cipla
  3. supreme court
  4. glivec
  5. nexavar
  6. bayer
  7. novartis
  8. big pharma
  9. sprycel
  10. pfizer
  11. herceptin
  12. bms
  13. delhi high court
  14. dasatinib
  15. knight cancer institute
  16. druker & rsquo
  17. bristol myers squibb
  18. dasitinib
  19. business standard
  20. barack obama
  21. sutent
  22. oregon health and sciences university
  23. food and drug administration
  24. trastuzumab
  25. bdr pharmaceuticals
  26. merck sharp & dohme
  27. supreme court & rsquo
  28. ciba-geigy
  29. bhupesh bhandari
  30. prathiba m singh

Top Coverage News


Coverage: The Match-Fixing Episode II - spot-fixing trial

Coverage of the match-fixing episode involving the Pakistan cricket team in England.

Complete coverage of Mumbai blasts

Three blasts rocked Mumbai's crowded Zaveri Bazar, Opera House and Dadar Kabootarkhana areas on...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z